NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
10.72
+1.40 (15.02%)
At close: May 6, 2026, 4:00 PM EDT
11.54
+0.82 (7.65%)
After-hours: May 6, 2026, 6:39 PM EDT
NextCure Market Cap
NextCure has a market cap or net worth of $38.67 million as of May 6, 2026. Its market cap has increased by 273.63% in one year.
Market Cap
38.67M
Enterprise Value
-1.31M
1-Year Change
273.63%
Ranking
Category
Stock Price
$10.72
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $38.67M, a decrease of -91.14%. That is a compound annual growth rate of -29.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 33.62M | -32.41% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evaxion | 37.95M |
| Veru Inc. | 36.27M |
| Grace Therapeutics | 36.13M |
| Pluri | 34.98M |
| Sensei Biotherapeutics | 34.87M |
| Apollomics | 34.81M |
| CervoMed | 34.53M |
| Boundless Bio | 34.51M |